PMID- 16249676 OWN - NLM STAT- MEDLINE DCOM- 20060125 LR - 20191210 IS - 0003-3022 (Print) IS - 0003-3022 (Linking) VI - 103 IP - 5 DP - 2005 Nov TI - Effect of halothane on galphai-3 and its coupling to the M2 muscarinic receptor. PG - 1015-25 AB - BACKGROUND: Halothane is an effective bronchodilator and inhibits airway smooth muscle contraction in part by inhibiting intracellular signaling pathways activated by the M2 muscarinic receptor and its cognate inhibitory heterotrimeric guanosine-5'-triphosphate (GTP)-binding protein (G protein), Gi. This study hypothesized that halothane inhibits nucleotide exchange at the alpha isoform-3 subunit of Gi (Galphai-3), but only when regulated by the M2 muscarinic receptor. METHODS: GTP hydrolysis by Galphai-3 and the Galphai-3beta1gamma2HF heterotrimer expressed in Spodoptera frugiperda cells was measured using a phosphohydrolase assay with [gammaPi]-labeled GTP. Anesthetic binding to Galphai-3 was measured by saturation transfer difference nuclear magnetic resonance spectroscopy. Galphai-3 nucleotide exchange was measured in crude membranes prepared from COS-7 cells transiently coexpressing the M2 muscarinic receptor and Galphai-3. A radioactive analog of GTP, [S]GTPgammaS, was used as a reporter for Galphai-3 nucleotide exchange. RESULTS: Although spectroscopy demonstrated halothane binding to Galphai-3, this binding had no effect on [gammaPi]-labeled GTP hydrolysis by the Galphai-3beta1gamma2HF heterotrimer expressed in Spodoptera frugiperda cells, nor basal Galphai-3 nucleotide exchange measured in crude membranes when the muscarinic receptor agonist acetylcholine was omitted from the assay. Conversely, halothane caused a concentration-dependent inhibition of Galphai-3 nucleotide exchange with acetylcholine included in the assay. CONCLUSION: These data indicate that despite halothane binding to Galphai-3, halothane has no direct inhibitory effect on the intrinsic activity of the Galphai-3beta1gamma2HF heterotrimer but inhibits M2 muscarinic receptor regulation of the heterotrimer. This novel effect is consistent with the ability of halothane to inhibit airway smooth muscle contraction and bronchoconstriction induced by acetylcholine. FAU - Jin, Fang AU - Jin F AD - Department of Anesthesiology, Mayo Foundation, Rochester, Minnesota 55905, USA. FAU - Wang, Shuyan AU - Wang S FAU - Spencer, Joshua D AU - Spencer JD FAU - Penheiter, Sumedha G AU - Penheiter SG FAU - Streiff, John H AU - Streiff JH FAU - Penheiter, Alan R AU - Penheiter AR FAU - Warner, David O AU - Warner DO FAU - Jones, Keith A AU - Jones KA LA - eng GR - HL-45532/HL/NHLBI NIH HHS/United States GR - HL-54757/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Anesthesiology JT - Anesthesiology JID - 1300217 RN - 0 (Anesthetics, Inhalation) RN - 0 (Guanine Nucleotides) RN - 0 (Receptor, Muscarinic M2) RN - 0 (Recombinant Proteins) RN - 86-01-1 (Guanosine Triphosphate) RN - EC 3.6.5.1 (GNAI3 protein, human) RN - EC 3.6.5.1 (GTP-Binding Protein alpha Subunits, Gi-Go) RN - N9YNS0M02X (Acetylcholine) RN - UQT9G45D1P (Halothane) SB - IM MH - Acetylcholine/pharmacology MH - Anesthetics, Inhalation/*pharmacology MH - Animals MH - Baculoviridae/metabolism MH - COS Cells MH - Cell Membrane/drug effects/metabolism MH - Chlorocebus aethiops MH - Escherichia coli/drug effects/metabolism MH - GTP-Binding Protein alpha Subunits, Gi-Go/biosynthesis/drug effects/*metabolism MH - Guanine Nucleotides/metabolism MH - Guanosine Triphosphate/metabolism MH - Halothane/*pharmacology MH - Humans MH - Magnetic Resonance Spectroscopy MH - Receptor, Muscarinic M2/biosynthesis/*drug effects MH - Recombinant Proteins/metabolism MH - Transfection EDAT- 2005/10/27 09:00 MHDA- 2006/01/26 09:00 CRDT- 2005/10/27 09:00 PHST- 2005/10/27 09:00 [pubmed] PHST- 2006/01/26 09:00 [medline] PHST- 2005/10/27 09:00 [entrez] AID - 00000542-200511000-00016 [pii] AID - 10.1097/00000542-200511000-00016 [doi] PST - ppublish SO - Anesthesiology. 2005 Nov;103(5):1015-25. doi: 10.1097/00000542-200511000-00016.